
On 12 Nov 2026 D. R. Horton closed at $144.45, +1.5% this year; market cap $40.14bn, P/E 13.9.
Consumer Discretionary · Homebuilding · NYSE · United States
D.R. Horton, Inc. operates as a homebuilding company in East, North, Southeast, South Central, Southwest, and Northwest regions in the United States. It engages in the acquisition and development of land; and construction and sale of residential homes in 126 markets across 36 states under the names of D.R. Horton. The company also constructs and sells single-family detached homes; and attached homes, such as townhomes and duplexes. In addition, it provides mortgage financing and title agency services; and engages in the residential lot development business. Further, the company develops, constructs, owns, leases, and sells multi-family and single-family rental properties; conducts insurance-related operations; and owns water rights and other water-related assets, as well as non-residential real estate, including ranch land and improvements. It primarily serves homebuyers. D.R. Horton, Inc. was founded in 1978 and is headquartered in Arlington, Texas.
| Market cap | $40.14bn |
| P/E (trailing) | 13.9 |
| EPS (TTM) | $10.40 |
| Beta | 1.37 |
| Dividend | $2.00 |
| Dividend yield | 1.38% |
| Ex-dividend date | 12 Nov 2026 |
| Latest report | 29 Oct 2026 |
| Next earnings | 28 Jan 2027 |
| YTD | +1.5% |
| 1Y | +0.5% |
| 3Y | +6.9% |
| 5Y | +9.3% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2026 | $33.04bn | $2.89bn | $3.35bn |
| 2025 | $34.25bn | $3.59bn | $3.28bn |
| 2024 | $36.80bn | $4.76bn | $2.02bn |
| 2023 | $35.46bn | $4.75bn | $4.16bn |
| 2022 | $33.48bn | $5.86bn | $413.60m |
We publish no single base value for D. R. Horton. Our valuation methods put it between $51.80 and $112.71 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method
Call and put prices: our price for each next to the market's.
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.